Stock INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Infant Bacterial Therapeutics AB (publ) Other OTC

Equities

Pharmaceuticals

Business Summary

Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.

Managers

Managers TitleAgeSince
Staffan Strömberg CEO
 Chief Executive Officer 57 12-12-31
Maria Ekdahl DFI
 Director of Finance/CFO 51 22-09-18
Erik Anders Kronström COO
 Chief Operating Officer 57 14-10-19
Jonas Rastad CTO
 Chief Tech/Sci/R&D Officer 74 -
Agneta Heierson PRN
 Corporate Officer/Principal - -
Leif Gallo LAW
 General Counsel 65 -
Michael Owens AUD
 Comptroller/Controller/Auditor 68 15-12-03

Members of the board

Members of the board TitleAgeSince
Margareta Hagman BRD
 Director/Board Member 58 15-09-23
Peter Michael Rothschild CHM
 Chairman 74 10-12-31
Anthon Jahreskog BRD
 Director/Board Member 44 17-05-03
Kristina Sjöblom Nygren BRD
 Director/Board Member 63 18-05-14
Eva Idén BRD
 Director/Board Member 58 17-05-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 453,283 0 0 87.87 %
Stock B 1 13,018,137 11,837,506 ( 90.93 %) 0

Shareholders

NameEquities%Valuation
Fjärde AP-fonden
10.32 %
1,344,000 10.32 % 11 M $
Annwall & Rothschild Investments AB
5.541 %
721,351 5.541 % 6 M $
Keel Capital AB
5.116 %
666,053 5.116 % 5 M $
AMF Fonder AB
4.624 %
601,902 4.624 % 5 M $
Unionen
4.087 %
532,023 4.087 % 4 M $
Tredje AP-fonden
4.020 %
523,367 4.020 % 4 M $
SEB Investment Management AB
3.405 %
443,250 3.405 % 4 M $
Ålandsbanken Fondbolag AB (Sweden)
3.146 %
409,524 3.146 % 3 M $
David Dangoor
2.825 %
367,705 2.825 % 3 M $
Banque Pictet & Cie SA (Investment Management)
2.390 %
311,169 2.390 % 3 M $
NameEquities%Valuation
Annwall & Rothschild Investments AB
100.00 %
453,283 100.00 % 4 M $

Company contact information

Infant Bacterial Therapeutics AB

Bryggargatan 10

111 21, Stockholm

+46 7 62 19 37 38

http://www.ibtherapeutics.com
address Infant Bacterial Therapeutics AB (publ)

Group companies

NameCategory and Sector
INFANT BACTERIAL THERAPEUTICS AB
Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MERCK KGAA Stock Merck KGaA
+18.88% 80.5B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+14.11% 9.15B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-14.14% 4.9B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+43.39% 4.49B
YUHAN CORPORATION Stock Yuhan Corporation
+18.90% 4.44B
INDIVIOR PLC Stock Indivior PLC
+7.93% 2.19B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-28.40% 2.13B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+15.93% 2.1B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-43.17% 1.78B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IBT B Stock
  4. Stock
  5. Company Infant Bacterial Therapeutics AB (publ)